AK1 and Parkinson disease: Even if the two human AK1s analyzed do not form the same interactions with amantadine, the observation could be aware of the efficacy of the amantadine in the late stages of PD, because, as mentioned earlier, AK1 activity could compensate for purine metabolism dysfunctions.